#64 Evolution of Treatment Paradigms in ANCA Vasculitis, with David Jayne

episode

A pinch of salt - A podcast by ERA not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Interviews | Danielle Brooks, Colin Kaepernick, Giri Nathan 51 min · 20 Sep 2026 · The Daily Show: Ears Edition

4AM ET 09/20/2026 Newscast 3 min · 20 Sep 2026 · Fox News Hourly Update

Day 263: The Father's Generosity (2026) 27 min · 20 Sep 2026 · The Bible in a Year (with Fr. Mike Schmitz)

Day 263: The Luminous Mysteries 12 min · 20 Sep 2026 · The Rosary in a Year (with Fr. Mark-Mary Ames)

NPR News: 09-20-2026 3AM EDT 5 min · 20 Sep 2026 · NPR News Now

Dave Wood: Be Your Own Voice - Pressure, Performance & Knowing When to Pull Back 1h 45m · 20 Sep 2026 · Between Two Beers Podcast

Report any issue

Source

Recorded12 Feb 2026

Publisherfeeds.buzzsprout.com

Handlerec:15868810

Show notes

Join A pinch of salt, as we sit down with David Jayne to trace the rapid transformation of ANCA-associated vasculitis care. From the historic cyclophosphamide–glucocorticoid backbone to biologics like rituximab and newer targeted strategies such as complement inhibition (including avacopan), this episode unpacks how clinicians can balance efficacy, safety, and quality of life—while looking ahead to what may define the next decade of treatment.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in